I.Financial Updates
1.UBS Upgrades Novartis to Neutral:Analysts highlight strong management confidence in core therapeutic areas and key mid-term drug candidates.(ID:20923077)
2.Barclays Downgrades Novartis to Underweight:Move follows strategic focus on Pelacarsen and pending regulatory approval.(ID:20898047)
3.Merck Shares Gain on Strong Earnings:Stock rose 1.6% with Q3 EPS reaching $2.32, reflecting robust performance.(ID:20980992)
4.Eli Lilly Stock Rises on Revenue Growth:Company reported 53.87% revenue increase to $17.6B in the latest quarter.(ID:20979621)
5.Danish GDP Boosted by Pharma Exports:Novo Nordisk’s obesity drugs drive 2.3% GDP growth in Q3, highlighting economic impact.(ID:20745346)
II.Regulatory and Compliance
1.Moderna Faces Audit Findings in UK:PMCPA identified 23 violations of medicines code, prompting government review of partnership.(ID:20892598)
2.Burkina Faso Seizes Counterfeit Drugs:Operation LADELI dismantles networks, seizing 150 fake drug batches to reduce public health risks.(ID:20868816)
3.Turkey Issues Arrests in Fake Prescription Scheme:112 million lira fraud involved falsifying patient data and issuing fake prescriptions at a hospital.(ID:20851009)
4.Quebec Pharmacists Challenge Pay Law:Law allows health minister to set pay by decree if negotiations fail within 60 days, creating uncertainty.(ID:20948688)
5.Peru Fines 13 Pharma Firms for Price Fixing:Companies colluded in public tenders between 2006 and 2020, inflating essential drug prices.(ID:21000059)
6.Brazil Pharmacy Shut for Expired Products:Inspection found 15 expired raw materials and lack of proper temperature control in storage.(ID:21024427)
III.Market Insights
1.Azelaic Acid Market to Reach $415.3M by 2033:Projected 7.2% CAGR driven by increasing pharmaceutical use and research in dermatological treatments.(ID:20891896)
2.Oleic Acid Market Expands to $1.188B by 2035:5.8% CAGR supported by demand in food, pharma, and cosmetics, with plant-based sources dominating.(ID:20984600)
3.Oleochemicals Gain Traction in Sustainability Push:Bio-based products boost market growth by 18% annually, especially in personal care and pharmaceutical sectors.(ID:20813776)
IV.Industry Events
1.OPPI Summit Emphasizes Partnership in India:Event highlights collaboration between industry and government, driving 75% of pharma innovation.(ID:20861283)
2.OPPI Summit Focuses on One Health Security:India’s health innovation and pandemic preparedness underscored, with over 100 vaccines developed.(ID:20988734)
3.Novartis Engages Youth at One Young World:Company sends professionals to summit on leadership, purpose, and social impact.(ID:20802990)
V.Production and Supply
1.Medicine Shortage Hits Astana During Flu Outbreak:Empty pharmacy shelves for basic drugs like antivirals and fever reducers due to surge in respiratory infections.(ID:20891279)
2.Lithuania Pharma Production Surges 48.8%:Industrial production value up 1.8%, with pharmaceuticals leading growth in October.(ID:20886418)
3.India Urges Reduction in API Imports:Minister calls for boosting local production to cut 40% import dependency on key ingredients.(ID:20835860)
VI.Policy and Pricing
1.Romania Expands Free and Subsidized Medicine List:New list includes innovative drugs for neurological and rare diseases, with 35% lower costs for generics.(ID:20859995)
2.Mexican Pharma Could Quadruple with Regulatory Reform:Modernizing framework and improving Cofepris efficiency key to boosting sector growth.(ID:20810137)
3.Oregon to Host Meeting on Drug Prices:Virtual event aims to address rising costs with expert presentations on biosimilars and drug financing.(ID:20827576)
4.Iran Drug Prices Surge Due to Currency Fluctuations:Costs increased 300% amid severe shortages in essential medicines.(ID:20835443)
5.Iran Implements Transparency in Drug Distribution:Titik system tracks supplies from production to delivery to combat fraud and ensure availability.(ID:20861425)
VII.Corporate News
1.Obituary of Ramón Biosca Carulla:Pharmaceutical Council expresses condolences for the loss of an industry figure.(ID:20925275)
2.Obituary of Businessman Panos Marinopoulos:He was involved in retail and pharmaceutical industries, leaving a legacy in the sector.(ID:20942891)
3.Seoul Exhibition Educates on Medicine Knowledge:Interactive displays cover drug history, function, and safety to boost public awareness.(ID:20822005)
4.Saudi Arabia Seeks US Pharma Investment:Market value at $70 billion, with pharmaceuticals at $11.5 billion, aligning with Vision 2030 goals.(ID:20862324)
5.Iran Considers Opium Cultivation for Medicine:Move aims to ensure raw material supply for drug production amid import disruptions.(ID:20921720)
Disclaimer: This is a curated digest of industry news from public sources. The information is for general insight and is not professional advice; readers should verify details independently. Please provide news ID when you need the original url.
PHARMACEUTICAL INDUSTRY PULSE
